The Conference's signature program will feature a Conversation with STEM Leaders sharing personal examples of inspiration, determination and grace. The impressive panel includes Donna Tempel, President and CEO, Drais Pharmaceuticals, Inc., and Vice Chairman of the Board of Trustees, BioNJ; Debbie Hart, President and CEO, BioNJ and Avis Yates Rivers, President and CEO, Technology Concepts Group International.
The wide breadth of topics to be explored through interactive sessions include Productive Conflict Resolution, Emotional Intelligence, Strategic Networking - Making it Work for You and Work/Life Integration. The day will also offer ample time for high-quality networking.
"The Inspiring Women in STEM Conference is all about professional development," said Vicki Gaddy, Vice President, Talent Services, BioNJ. "We have a top notch roster of speakers who will inspire us with their stories." Speakers include Dr. Robyn Odegaard, CEO, Champion Performance Development; Dawn Bell, Vice President, Global Program Head, Novartis; Judith Sheft, Associate Vice President, Technology Development, NJIT; Lynn Anderson, Esq., Partner, Drinker, Middle & Reath; Peggy McHale, Co-founder and Owner, Consultants 2 Go; Michele Brown, President and Founder, IntuAction Coaching; Dr. Teresa Boyer, Assistant Professor and Executive Directory, Rutgers University School of Management Center for Women and Work; as well as Vicki Carey, Vice President, U.S. Commercial Lead & Head of Global Marketing, Praluent; Karen Sheehy, Vice President, Head, North American Compliance; and Margaret Sparks, Vice President, Global Program Head from Sanofi.
The Early Bird Registration Price for the Conference is $295 for BioNJ Members and affiliated organizations and $395 for future BioNJ Members. Prices will increase after October 30. Click here to register. For more information, visit www.BioNJ.org or call (609) 890-3185. If you are interested in sponsoring the Inspiring Women in STEM Conference, please contact Vicki Gaddy at VGaddy@BioNJ.org.
BioNJ, The Gateway to Health, is a powerful network of 400 Member Investors representing research-based life sciences companies and stakeholders dedicated to propelling a vibrant ecosystem where Science is Supported, Companies are Created, Drugs are Developed and Patients are Paramount. Because Patients Can't WaitSM, BioNJ is committed to the growth and prosperity of New Jersey's life sciences ecosystem to help accelerate the discovery, development and commercialization of therapies and cures that save and improve lives and lessen the burden of illness and disease to society. As the industry's voice in New Jersey, we fulfill our Mission to help our Members help Patients by driving capital formation and fostering entrepreneurship, advocating for public policies that advance medical innovation, providing access to talent and education and offering a cost-saving array of critical commercial resources. For more information about BioNJ, please visit www.BioNJ.org.